|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 3 425-437, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
M von Schlippe, JF Marshall, P Perry, M Stone, AJ Zhu and IR Hart
Richard Dimbleby Department of Cancer Research, Imperial Cancer Research Fund, Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK.
We have demonstrated the possibility of cross-talk between E-cadherin and alphav integrins in breast carcinoma cells. Using the function-blocking anti-alphav monoclonal antibody 17E6, applied to monolayer cultures of breast cancer lines, it was found that treatment of cells possessing detergent-insoluble (implying attachment to the actin cytoskeleton) E-cadherin resulted in the adoption of a spheroid configuration of cell growth. This effect was dependent upon not just alphav occupancy but also receptor aggregation. Thus in vitro alphav-dependent adhesion suppresses E-cadherin-mediated morphological changes. To investigate whether manipulation of E-cadherin would, conversely, modulate integrin activity we introduced a dominant-negative E-cadherin construct into one of the lines, ZR75-1, giving rise to the cell line ZR-E2R1. Surface expression of endogenous E-cadherin was downregulated (by around 25%), whereas beta-catenin levels were increased two- to threefold in ZR-E2R1 cells. There was also a highly significant increase in migration of ZR-E2R1 cells (relative to control cells) toward vitronectin (P<0.001), but not toward collagen type I, fibronectin or laminin. Such increased migration could be abrogated totally by antibody blockade of alphavbeta5 and alphavbeta1 integrins. There was no detectable change in alphav integrin levels. These data suggest that the introduction of a dominant-negative E-cadherin mutant into ZR75-1, in addition to a loss of cohesion, generates a signal (or signals) which increases migration towards vitronectin through increased activity of alphav integrins.
This article has been cited by other articles:
![]() |
Z. Liao, C. I. Seye, G. A. Weisman, and L. Erb The P2Y2 nucleotide receptor requires interaction with {alpha}v integrins to access and activate G12 J. Cell Sci., May 1, 2007; 120(9): 1654 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, A. Alt-Holland, A. Margulis, Y. Shamis, N. E. Fusenig, U. Rodeck, and J. A. Garlick E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion J. Cell Sci., January 15, 2006; 119(2): 283 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Andersen, J. Mejlvang, S. Mahmood, I. Gromova, P. Gromov, E. Lukanidin, M. Kriajevska, J. K. Mellon, and E. Tulchinsky Immediate and Delayed Effects of E-Cadherin Inhibition on Gene Regulation and Cell Motility in Human Epidermoid Carcinoma Cells Mol. Cell. Biol., October 15, 2005; 25(20): 9138 - 9150. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Balzac, M. Avolio, S. Degani, I. Kaverina, M. Torti, L. Silengo, J. V. Small, and S. F. Retta E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function J. Cell Sci., October 15, 2005; 118(20): 4765 - 4783. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Margulis, W. Zhang, A. Alt-Holland, H. C. Crawford, N. E. Fusenig, and J. A. Garlick E-cadherin Suppression Accelerates Squamous Cell Carcinoma Progression in Three-Dimensional, Human Tissue Constructs Cancer Res., March 1, 2005; 65(5): 1783 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H.J. Danen, P. Sonneveld, C. Brakebusch, R. Fassler, and A. Sonnenberg The fibronectin-binding integrins {alpha}5{beta}1 and {alpha}v{beta}3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis J. Cell Biol., December 23, 2002; 159(6): 1071 - 1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, M. Bewick, and R. M. Lafrenie Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase Carcinogenesis, July 1, 2002; 23(7): 1251 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Menke, C. Philippi, R. Vogelmann, B. Seidel, M. P. Lutz, G. Adler, and D. Wedlich Down-Regulation of E-Cadherin Gene Expression by Collagen Type I and Type III in Pancreatic Cancer Cell Lines Cancer Res., April 1, 2001; 61(8): 3508 - 3517. [Abstract] [Full Text] |
||||